Fibrotic and vascular remodelling of colonic wall in patients with active ulcerative colitis

Journal of Crohn's and Colitis

Volumn 10, Issue 10, 2016, Pages 1194-1204

  Ippolito, Chiara ^a   Colucci, Rocchina ^a   Segnani, Cristina ^a   Errede, Mariella ^b   Girolamo, Francesco ^b   Virgintino, Daniela ^b   Dolfi, Amelio ^a   Tirotta, Erika ^a   Buccianti, Piero ^c   Di Candio, Giulio ^c   Campani, Daniela ^c   Castagna, Maura ^c   Bassotti, Gabrio ^d   Villanacci, Vincenzo ^e   Blandizzi, Corrado ^a   Bernardini, Nunzia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e SPEDALI CIVILI   (Italy)

Author keywords

Active disease; Colonic muscle remodelling; Intestinal angiogenesis; Intestinal fibrosis; Ulcerative colitis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CELL NUCLEUS ANTIGEN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DESMIN; ENDOGLIN; FIBRONECTIN; NESTIN; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VIMENTIN; BIOLOGICAL MARKER;

ADULT; AGED; ANGIOGENESIS; ANTIBODY LABELING; ARTICLE; CANCER PATIENT; CELL PROLIFERATION; CLINICAL ARTICLE; COLON RESECTION; COLON TISSUE; CONTROLLED STUDY; ELASTIC FIBER; ENDOTHELIUM CELL; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATORY BOWEL DISEASE; INTESTINAL FIBROSIS; INTESTINE WALL; MALE; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; UPREGULATION; WESTERN BLOTTING; ACUTE DISEASE; CASE CONTROL STUDY; COLON; DISEASE COURSE; FIBROSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; SINGLE BLIND PROCEDURE; VASCULAR REMODELING; VASCULARIZATION;

ACUTE DISEASE; ADULT; AGED; BIOMARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; VASCULAR REMODELING;

EID: 84978279442     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw076     Document Type: Article

References (42)

1. Busch K, Sonnenberg A, Bansback N. Impact of inflammatory bowel disease on disability. Curr Gastroenterol Rep 2014;16:414
2. Haase AM, Gregersen T, Christensen LA, et al. Regional gastrointestinal transit times in severe ulcerative colitis. Neurogastroenterol Motil 2016;28:217-24
3. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474:307-17
4. Rieder F, de Bruyn JR, Pham BT, et al. Results of the Fourth scientific workshop of the ECCO [Group II]: Markers of intestinal fibrosis in inflammatory bowel disease. J Crohns Colitis 2014;8:1166-78
5. Latella G, Rogler G, Bamias G, et al. Results of the Fourth scientific workshop of the ECCO [I]: Pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis 2014;8:1147-65
6. D'Haens G, Bressler B, Danese S, Gibson P, Hanauer SB, Sandborn W. The Crohn's Disease-Ulcerative Colitis Clinical Appraisal. Clin Gastroenterol Hepatol 2016;14:6389
7. Gordon IO, Agrawal N, Goldblum JR, Fiocchi C, Rieder F. Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. Inflamm Bowel Dis 2014;20:2198-206
8. Torres J, Billioud V, Sachar DB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis as a progressive disease: the forgotten evidence. Inflamm Bowel Dis 2012;18:1356-63
9. Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis 2001;7:226-36
10. de Bruyn JR, Meijer SL, Wildenberg ME, Bemelman WA, van den Brink GR, D'Haens GR. Development of fibrosis in acute and longstanding ulcerative colitis. J Crohns Colitis 2015;9:966-72
11. Lund PK, Zuniga CC. Intestinal fibrosis in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol 2001;17:318-23
12. Marlow SL, Blennerhassett MG. Deficient innervation characterizes intestinal strictures in a rat model of colitis. Exp Mol Pathol 2006;80:54-66
13. Nair DG, Han TY, Lourenssen S, Blennerhassett MG. Proliferation modulates intestinal smooth muscle phenotype in vitro and in colitis in vivo. Am J Physiol Gastrointest Liver Physiol 2011;300:G903-13
14. Rieder F, Kessler SP, West GA, et al. Inflammation-induced endothelial-tomesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol 2011;179:2660-73
15. Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011;17:578-93
16. Sutherland LR, Martin F. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada. Dig Dis Sci 1987;32:646S
17. Geboes K, Riddell R, öst A, Jensfelt B, Persson T, Löfberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000;47:404-9
18. Langner C, Magro F, Driessen A, et al. The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch 2014;464:511-27
19. Ippolito C, Segnani C, Errede M, et al. An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. J Cell Mol Med 2015;19:485-500
20. Segnani C, Ippolito C, Antonioli L, et al. Histochemical detection of collagen fibres by Sirius Red/Fast Green is more sensitive than van Gieson or Sirius Red alone in normal and inflamed rat colon. PLoS One 2015;10:e0144630
21. Bernardini N, Segnani C, Ippolito C, et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med 2012;16:318-27
22. Virgintino D, Errede M, Rizzi M, et al. The CXCL12/CXCR4/CXCR7 ligand-receptor system regulates neuro-glio-vascular interactions and vessel growth during human brain development. J Inherit Metab Dis 2013;36:455-66
23. Mouton PR, Gokhale AM, Ward NL, West MJ. Stereological length estimation using spherical probes. J Micros 2002;206:54-64
24. Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006;130:2060-73
25. Danese S, Scaldaferri F, Vetrano S, et al. Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut 2007;56:1248-56
26. Hatoum OA, Heidemann J, Binion DG. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Ann N Y Acad Sci 2006;1072:78-97
27. Pousa ID, Maté J, Gisbert JP. Angiogenesis in inflammatory bowel disease. Eur J Clin Invest 2008;38:73-81
28. Knod JL, Crawford K, Dusing M, Collins MH, Chernoguz A, Frischer JS. Angiogenesis and vascular endothelial growth factor A expression associated with inflammation in pediatric Crohn's disease. J Gastrointest Surg 2016;20:624-30
29. Suzuki K, Sun X, Nagata M, et al. Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium. Pathology Int 2011;61:228-38
30. Zhu MY, Lu YM, Ou YX, Zhang HZ, Chen WX. Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model. J Digest Dis 2012;13:421-9
31. Lawrance IC, Rogler G, Bamias G, et al. Cellular and molecular mediators of intestinal fibrosis. J Crohns Colitis 2015 Nov 2. pii: j.crohns.2014.09.008. [Epub, ahead of print.]
32. Manetti M, Rosa I, Messerini L, Ibba-Manneschi L. Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis. J Cell Mol Med 2015;19:62-73
33. Kolachala VL, Bajaj R, Wang L, et al. Epithelial-derived fibronectin expression, signaling, and function in intestinal inflammation. J Biol Chem 2007;282:32965-73
34. Schemann M, Neunlist M. The human enteric nervous system. Neurogastroentol Motil 2004;16:55-9
35. Bernardini N, Ippolito C, Segnani C, et al. Histopathology in gastrointestinal neuromuscular diseases: methodological and ontological issues. Adv Anat Pathol 2013;20:17-31
36. Bassotti G, Villanacci V, Nascimbeni R, et al. Enteric neuroglial apoptosis in inflammatory bowel diseases. J Crohns Colitis 2009;3:264-70
37. Yamagata M, Mikami T, Tsuruta T, et al. Submucosal fibrosis and basicfibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis. Digestion 2011;84:12-21
38. Bassotti G, Antonelli E, Villanacci V, Salemme M, Coppola M, Annese V. Gastrointestinal motility disorders in inflammatory bowel diseases. World J Gastroenterol 2014;20:37-44
39. Johnson LA, Rodansky ES, Sauder KL, et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis 2013;19:891-903
40. Johnson LA, Rodansky ES, Haak AJ, Larsen SD, Neubig RR, Higgins PDR. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-beta-induced fibrogenesis in human colonic myofibroblasts. Inflamm Bowel Dis 2014;20:154-65
41. Huang Y, Xiao S, Jiang Q. Role of Rho kinase signal pathway in inflammatory bowel disease. Int J Clin Exp Med 2015;8:3089-97
42. Bourgier C, Haydont V, Milliat F, et al. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 2005;54:336-43